The global biomarker research services market is estimated to be valued at USD 10.98 Bn in 2025 and is expected to reach USD 310.66 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 61% from 2025 to 2032.
To learn more about this report, Request sample copy
Advancements in proteomics and metabolomics along with increasing R&D investments by pharmaceutical and biotechnology companies for the development of personalized medicines are fueling the market growth. The demand of biomarker research services is increasing in therapeutics such as oncology, cardiovascular disease, and neurological disorder for developing targeted therapies which assess disease severity and guides physicians in clinical management of patients. Biomarker research has wide applications in drug discovery and development as well as in clinical research which is expected to support the expansion of this market over the forecast period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients